We are working on target-based drug delivery for cancer treatment and diagnostics.
Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells. It is the second most common cause of death worldwide and is one of the leading causes of morbidity. Its prevalence is growing despite the availability of latest and bespoke medicines. Some of the major reasons being delayed detection besides very high systemic toxicity.
Our oncology research program is directed towards reducing cancer mortality by developing products that are site-specific with reduced side effects and developing technologies for early detection of cancer.More
The team is working on target-based drug delivery for cancer treatment. The Company has designed a platform technology with a novel concept of triple conjugate i.e., Drug-Protein-Polymer-Conjugate (DPPC) for the purpose.More
The team at VMRC is working to provide early diagnosis solutions for cancer which is cost-effective, easy to use, and can be integrated with easily available tools.More
We are fuelling our research pipeline with innovative solutions to solve some of the world's most important and toughest healthcare challenges in the areas of Oncology.More
Copyright © 2019 VMRCINDIA All Rights Reserved last Update: 17 July 2020